Astrana Health, Inc. (ASTH)
USD 28.2
(-2.12%)
USD 28.2
(-2.12%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 296.26 Million USD | 31.92% |
| 2022 | 224.57 Million USD | 13.95% |
| 2021 | 197.08 Million USD | -20.01% |
| 2020 | 246.38 Million USD | 6.12% |
| 2019 | 232.17 Million USD | 1685.94% |
| 2018 | 13 Million USD | 13066.16% |
| 2017 | 98.73 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 368.44 Million USD | 42.29% |
| 2024 Q2 | 425 Million USD | 15.35% |
| 2023 FY | 296.26 Million USD | 31.92% |
| 2023 Q3 | 228.41 Million USD | 1.94% |
| 2023 Q4 | 296.26 Million USD | 29.7% |
| 2023 Q2 | 224.06 Million USD | -0.08% |
| 2023 Q1 | 224.24 Million USD | 10.25% |
| 2022 Q2 | 199.06 Million USD | 8.72% |
| 2022 FY | 224.57 Million USD | 13.95% |
| 2022 Q4 | 203.38 Million USD | 2.13% |
| 2022 Q3 | 199.15 Million USD | 0.04% |
| 2022 Q1 | 183.1 Million USD | 0.1% |
| 2021 Q2 | 182.7 Million USD | 0.0% |
| 2021 FY | 197.08 Million USD | -20.01% |
| 2021 Q3 | 182.81 Million USD | 0.06% |
| 2021 Q4 | 182.91 Million USD | 0.06% |
| 2020 FY | 246.38 Million USD | 6.12% |
| 2019 FY | 232.17 Million USD | 1685.94% |
| 2018 FY | 13 Million USD | 13066.16% |
| 2017 FY | 98.73 Thousand USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 77.933% |
| Addus HomeCare Corporation | 124.13 Million USD | -138.666% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -326.256% |
| Amedisys, Inc. | 346.76 Million USD | 14.564% |
| American Oncology Network, Inc. | 120.44 Million USD | -145.974% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 76.788% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -177.84% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -3091.788% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -11025.084% |
| COMPASS Pathways plc | 28.75 Million USD | -930.222% |
| DocGo Inc. | 15.16 Million USD | -1853.981% |
| The Ensign Group, Inc. | 1.78 Billion USD | 83.401% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -2536.947% |
| InnovAge Holding Corp. | 100.49 Million USD | -194.799% |
| Assure Holdings Corp. | 505 Thousand USD | -58565.545% |
| The Joint Corp. | 2 Million USD | -14713.05% |
| LifeStance Health Group, Inc. | 280.28 Million USD | -5.7% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -77569.3% |
| ModivCare Inc. | 983.75 Million USD | 69.885% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -248902.765% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -16746.268% |
| Option Care Health, Inc. | 1.05 Billion USD | 71.962% |
| P3 Health Partners Inc. | 108.31 Million USD | -173.508% |
| P3 Health Partners Inc. | 108.31 Million USD | -173.508% |
| The Pennant Group, Inc. | 312.51 Million USD | 5.2% |
| Surgery Partners, Inc. | 2.03 Billion USD | 85.432% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -241.212% |
| The Oncology Institute, Inc. | 86.82 Million USD | -241.212% |